1,538
Views
7
CrossRef citations to date
0
Altmetric
Editorials

Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functions

Pages 671-676 | Received 03 Feb 2017, Accepted 07 Feb 2017, Published online: 24 Feb 2017

References

  • Chang TMS. Semipermeable microcapsules. Science. 1964;146:524–525.
  • Chang TMS. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Commun. 1971;44:1531–1536.
  • Chang TMS. 2005. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov. 4:221–235.
  • Chang TMS. Opening chapter on artificial cells that started nanomedicine. In: Chang TMS, editor. 2013. Selected topics in nanomedgicine. McGill University, Canada: World Science Publisher/Imperial College Press.
  • Chang TMS. Monograph on artificial cells: biotechnology, nanotechnology, blood substitutes, regenerative medicine, bioencapsulation, cell/stem cell therapy. World Scientific Publisher/Imperial College Press; 2007. p. 1–435. Available from: http://www.medicine.mcgill.ca/artcell/2007%20ebook%20artcell%20web.pdf
  • Mer M, Hodgson E, Wallis L, et al. Hemoglobin glutamer-250 (bovine) in South Africa: consensus usage guidelines from clinician experts who have treated patients. Transfusion. 2016;56:2631–2636.
  • Moore E, Moore FA, Fabian TC, et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009;208:1–13.
  • Kim HW, Greenburg AG, editors. Hemoglobin-based oxygen carriers as red cell substitutes and oxygen therapeutics. New York, London: Springer; 2014. p. 738.
  • D’Agnillo F, Chang TMS. PolyHb-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol. 1998;16:667–671.
  • Ma L, Hsia CJC. Polynitroxylated Hb as a multifunctional therapeutic for critical care and transfusion medicine. In: Chang TMS, editor Selected topics in nanomedicine. Singapore, London: World Science Publisher/Imperial College Press; 2013. pp. 169–194.
  • Sims C, Seigne P, Menconi M, et al. Skeletal muscle acidosis correlates with the severity of blood volume loss during shock and resuscitation. J Trauma. 2001;51:1137–1146.
  • Tronstad C, Pischke SE, Holhjem L, et al. Early detection of cardiac ischemia using a conductometric pCO(2) sensor: real-time drift correction and parameterization. Physiol Meas. 2010;31:1241–1255.
  • Bian Y, Chang TMS. A novel nanobiotherapeutical Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a 90 minutes sustained severe hemorrhagic shock rat model with 2/3 blood volume loss. Artif Cells Nanomed Biotechnol. 2015;43:1–9.
  • Guo C, Gynn M, Chang E. Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase. J Artif Cells Nanomed Biotechnol. 2015;43:157–162.
  • Bian Y, Guo C, Chang TMS. Temperature stability of Poly-[hemoglobin-superoxide dismutase–catalase- carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at −80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C. Artif Cells Nanomed Biotechnol. 2016;44:41–47.
  • Guo C, Chang TMS. Immunological properties of different types of Poly-[Hb-SOD-CAT-CA] (personal communication).
  • Wong N, Chang TMS. PolyHb-fibrinogen: a novel blood substitutes with platelet-like activity for extreme hemodilution. Artif Cell Blood Sub Biotechnol. 2007;35:481–489.
  • Artificial cells, blood substitutes and nanomedicine. Available from: http://www.medicine.mcgill.ca/artcell/http://www.artcell.mcgill.ca